Company · CIK 1761918
Erasca, Inc.
| CIK | 1761918 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ERAS (Nasdaq) |
| First annual or quarterly report | 2021-08-26 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297427 | 2026-07-13 | 2026-07-14 | 3 | |
| 333-289537 | 2025-08-12 | 2026-01-22 | 4 | |
| 333-266802 | 2022-08-11 | 2024-05-17 | 4 | |
| 333-279261 | 2024-05-09 | 2024-05-16 | 2 | |
| 333-257436 | 2021-06-25 | 2021-07-16 | 4 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-14 | 424B5Shelf takedown | 333-297427 | 0001193125-26-303352 |
| 2026-07-13 | 424B5Shelf takedown | 333-297427 | 0001193125-26-302148 |
| 2026-07-13 | S-3ASRShelf registered | 333-297427 | 0001193125-26-302035 |
| 2026-01-22 | 424B5Shelf takedown | 333-289537 | 0001193125-26-019641 |
| 2026-01-20 | 424B5Shelf takedown | 333-289537 | 0001193125-26-016549 |
| 2025-08-22 | EFFECTDeclared effective | 333-289537 | 9999999995-25-002722 |
| 2025-08-12 | S-3Shelf registered | 333-289537 | 0001193125-25-179038 |
| 2024-05-17 | 424B5Shelf takedown | 333-266802 | 0001193125-24-141858 |
| 2024-05-16 | EFFECTDeclared effective | 333-279261 | 9999999995-24-001559 |
| 2024-05-09 | S-3Shelf registered | 333-279261 | 0001193125-24-135289 |
| 2022-12-09 | 424B5Shelf takedown | 333-266802 | 0001193125-22-301897 |
| 2022-08-18 | EFFECTDeclared effective | 333-266802 | 9999999995-22-002436 |
| 2022-08-11 | S-3Shelf registered | 333-266802 | 0001193125-22-218726 |
| 2021-07-16 | 424B4Final prospectus | 333-257436 | 0001193125-21-217534 |
| 2021-07-15 | EFFECTDeclared effective | 333-257436 | 9999999995-21-002792 |
| 2021-07-12 | S-1/AAmendment | 333-257436 | 0001193125-21-212361 |
| 2021-06-25 | S-1Registration filed | 333-257436 | 0001193125-21-200537 |
| 2021-05-07 | DRSDraft made public | 377-04809 | 0000950123-21-005597 |